Sandoz launches SYMJEPI Injection in US to help treat allergic reactions Medical Dialogues Bureau13 July 2019 9:32 AM ISTSYMJEPI is a small, single-dose, pre-filled syringe and device combination as an alternative to epinephrine auto-injectors for the emergency treatment...
Novartis division resubmits USFDA application for biosimilar Pegfilgrastim Farhat Nasim4 April 2019 9:15 AM ISTNew Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...